Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317653893> ?p ?o ?g. }
- W4317653893 abstract "Escherichia coli (E. coli) is an opportunistic pathogen that can cause clinical mastitis in dairy cows worldwide. Mastitis produces severe symptoms in dairy cows, such as udder inflammation, the production of harmful substances, reduced milk production, and altered milk quality. Intramammary injections of rifaximin have a beneficial effect on dairy cow mastitis, especially for mastitis caused by E. coli. However, we do not know whether the currently accepted clinical administration scheme is reasonable. Therefore, the purpose of this experiment was to evaluate the clinical dosing regimen for curing mastitis induced by E. coli. In this study, the pharmacokinetics of four single dose groups (50, 100, 200, and 400 µg/gland) were studied in CD-1 lactating mice, and the main pharmacokinetic parameters were obtained by non-compartment and two-compartment model of Phoenix 8.1 software. A total of 5,000 colony-forming units (CFU) of E. coli ATCC25922 were injected into the mammary glands of mice under anatomic microscope guidance. After 12 h of growth in vivo, the mouse mastitis model was successfully developed. In pharmacodynamics experiment, 12 different dosing regimens (doses ranged from 25 to 800 µg/gland and two dosing intervals of 12 and 24 h) were used to study the therapeutic potential of rifaximin for mastitis. The PK/PD model was established by integrating pharmacokinetics and pharmacodynamics using the inhibitory sigmoid Emax model. The optimal antibacterial effect was 2log10CFU/gland reduction of bacterial colony counts in vivo, when the magnitude of AUC24/MIC exceeded 57.80 h. A total of 57.80 h of AUC24/MIC was defined as a target value in the Monte Carlo simulation. The clinically recommended dosage regimen of 100 mg/gland every 12 h in a day achieved a 91.08% cure rate for the treatment of bovine mastitis caused by E. coli infection." @default.
- W4317653893 created "2023-01-21" @default.
- W4317653893 creator A5031234889 @default.
- W4317653893 creator A5047621639 @default.
- W4317653893 creator A5054921518 @default.
- W4317653893 creator A5063253432 @default.
- W4317653893 creator A5064497244 @default.
- W4317653893 creator A5065456014 @default.
- W4317653893 creator A5080652141 @default.
- W4317653893 creator A5082580072 @default.
- W4317653893 creator A5083967530 @default.
- W4317653893 date "2023-01-21" @default.
- W4317653893 modified "2023-09-25" @default.
- W4317653893 title "A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coli" @default.
- W4317653893 cites W1909177655 @default.
- W4317653893 cites W1969871580 @default.
- W4317653893 cites W1974665820 @default.
- W4317653893 cites W1991810682 @default.
- W4317653893 cites W1997035847 @default.
- W4317653893 cites W2007331931 @default.
- W4317653893 cites W2028373209 @default.
- W4317653893 cites W2028831892 @default.
- W4317653893 cites W2035174162 @default.
- W4317653893 cites W2068581899 @default.
- W4317653893 cites W2075798278 @default.
- W4317653893 cites W2077100610 @default.
- W4317653893 cites W2101490239 @default.
- W4317653893 cites W2106427882 @default.
- W4317653893 cites W2115215601 @default.
- W4317653893 cites W2138177332 @default.
- W4317653893 cites W2211317280 @default.
- W4317653893 cites W2528899389 @default.
- W4317653893 cites W2740518283 @default.
- W4317653893 cites W2766159196 @default.
- W4317653893 cites W2775258386 @default.
- W4317653893 cites W2953611986 @default.
- W4317653893 cites W2996512289 @default.
- W4317653893 cites W3035847097 @default.
- W4317653893 cites W3171271669 @default.
- W4317653893 cites W3197710097 @default.
- W4317653893 doi "https://doi.org/10.1186/s12917-022-03564-2" @default.
- W4317653893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36681807" @default.
- W4317653893 hasPublicationYear "2023" @default.
- W4317653893 type Work @default.
- W4317653893 citedByCount "0" @default.
- W4317653893 crossrefType "journal-article" @default.
- W4317653893 hasAuthorship W4317653893A5031234889 @default.
- W4317653893 hasAuthorship W4317653893A5047621639 @default.
- W4317653893 hasAuthorship W4317653893A5054921518 @default.
- W4317653893 hasAuthorship W4317653893A5063253432 @default.
- W4317653893 hasAuthorship W4317653893A5064497244 @default.
- W4317653893 hasAuthorship W4317653893A5065456014 @default.
- W4317653893 hasAuthorship W4317653893A5080652141 @default.
- W4317653893 hasAuthorship W4317653893A5082580072 @default.
- W4317653893 hasAuthorship W4317653893A5083967530 @default.
- W4317653893 hasBestOaLocation W43176538931 @default.
- W4317653893 hasConcept C104317684 @default.
- W4317653893 hasConcept C111113717 @default.
- W4317653893 hasConcept C112705442 @default.
- W4317653893 hasConcept C142724271 @default.
- W4317653893 hasConcept C2776344049 @default.
- W4317653893 hasConcept C2776921810 @default.
- W4317653893 hasConcept C2777288759 @default.
- W4317653893 hasConcept C42972112 @default.
- W4317653893 hasConcept C501593827 @default.
- W4317653893 hasConcept C547475151 @default.
- W4317653893 hasConcept C55493867 @default.
- W4317653893 hasConcept C71924100 @default.
- W4317653893 hasConcept C86803240 @default.
- W4317653893 hasConcept C89423630 @default.
- W4317653893 hasConcept C98274493 @default.
- W4317653893 hasConceptScore W4317653893C104317684 @default.
- W4317653893 hasConceptScore W4317653893C111113717 @default.
- W4317653893 hasConceptScore W4317653893C112705442 @default.
- W4317653893 hasConceptScore W4317653893C142724271 @default.
- W4317653893 hasConceptScore W4317653893C2776344049 @default.
- W4317653893 hasConceptScore W4317653893C2776921810 @default.
- W4317653893 hasConceptScore W4317653893C2777288759 @default.
- W4317653893 hasConceptScore W4317653893C42972112 @default.
- W4317653893 hasConceptScore W4317653893C501593827 @default.
- W4317653893 hasConceptScore W4317653893C547475151 @default.
- W4317653893 hasConceptScore W4317653893C55493867 @default.
- W4317653893 hasConceptScore W4317653893C71924100 @default.
- W4317653893 hasConceptScore W4317653893C86803240 @default.
- W4317653893 hasConceptScore W4317653893C89423630 @default.
- W4317653893 hasConceptScore W4317653893C98274493 @default.
- W4317653893 hasIssue "1" @default.
- W4317653893 hasLocation W43176538931 @default.
- W4317653893 hasLocation W43176538932 @default.
- W4317653893 hasLocation W43176538933 @default.
- W4317653893 hasOpenAccess W4317653893 @default.
- W4317653893 hasPrimaryLocation W43176538931 @default.
- W4317653893 hasRelatedWork W18383156 @default.
- W4317653893 hasRelatedWork W2021319218 @default.
- W4317653893 hasRelatedWork W2059327436 @default.
- W4317653893 hasRelatedWork W2145518170 @default.
- W4317653893 hasRelatedWork W2227061539 @default.
- W4317653893 hasRelatedWork W2333368128 @default.
- W4317653893 hasRelatedWork W2357670862 @default.
- W4317653893 hasRelatedWork W3021369409 @default.